digipharm®
Home •  Site Map  •  Research  •  Reports  •  International Experts  •  Music Preparations  •  Fundamentals  •  News  •  Questions  •  Shop
digipharm®
peter huebner • micro music laboratories
M E D I C A L   R E S O N A N C E   T H E R A P Y   M U S I C®
R E D U C T I O N   O F   P S Y C H O – P H Y S I O L O G I C A L   M A N I F E S T A T I O N S   O F   S T R E S S

SCIENTIFIC RESEARCH

Research Fields Summary

Headaches

Migraine

Sleep Disorders

Pains

Neurodermatitis

Psoriasis

Medication Consumption

Dermatology

Dispersion of Stress

Faster Recovery

Mental Distress / Fear

Dizziness

Cardiovascular System

Hormone / Immune System

The Mental State

Operations

Radiation Sickness

ENT

Multiple Sclerosis

Gerontology

Diabetes

Cerebral & Nervous System

Mental & Sensory Abilities

Pediatrics

Pregnancy & Birth

Gynecology

Epilepsy

Concentration / Memory

Courage to Face Life

Creativity

Harmony

Mother & Child

Neurophysiological &
Sensory Disorders

Relaxation

Vital Energy

 

 






Scientific Studies and Clinical Observations
SLEEP DISORDERS
  • Significant reduction in sleep disorders in 81% of a group of female diabetes patients.
  • Improved sleep in 77% of the female patients with a mild form of OPH syndrome
  • Reduction in sleep disorders in patients suffering from severe radiation sickness: prior to treatment 95% of the reports documented sleeping disorders; after 10 days’ treatment this had fallen to an average of only 17%
  • Regular deep relaxation and relieving improvement in sleep in patients with psycho-vegetative syndrome
  • Normalization of sleep following surgery in 70%, compared to 57% in the medication group
  • Reduction in sleep disorders in 43% of patients with severe migraines
  • Normalization of sleep in 61% of pregnant women, compared to 30% in the medication group
  • Reduction in sleep disorders in pregnant women with somatic disorders. Prior to treatment incidence of recorded sleep disorders stood at 86%, after treatment this had fallen to only 7%.
    In the control group: prior to treatment 50%, after treatment an increase to 80%.


  For this indication please use the program:

SLEEP DISORDERS
 
 
 

   If you want to look at the studies in detail, please visit:

With kind permission of AAR EDITION INTERNATIONAL
© 1998-  DIGIPHARM >